LC
AMRX icon

Lindbrook Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Lindbrook Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.28K Hold
511
– – ﹤0.01% 2016
2024
Q4 		$4.05K Hold
511
– – ﹤0.01% 2082
2024
Q3 		$4.25K Sell
511
-77
-13% -$602 ﹤0.01% 2074
2024
Q2 		$3.73K Buy
588
+77
+15% +$489 ﹤0.01% 2128
2024
Q1 		$3.1K Buy
511
+9
+2% +$51 ﹤0.01% 2090
2023
Q4 		$3.05K Hold
502
– – ﹤0.01% 2110
2023
Q3 		$2.12K Hold
502
– – ﹤0.01% 2105
2023
Q2 		$1.56K Buy
+502
New +$1.07K ﹤0.01% 2247
2023
Q1 		– Sell
-78
Closed -$155 – 2778
2022
Q4 		$155 Sell
78
-33
-30% -$74 ﹤0.01% 2771
2022
Q3 		$0 Sell
111
-592
-84% -$1.66K ﹤0.01% 2606
2022
Q2 		$2K Buy
703
+539
+329% +$1.95K ﹤0.01% 1901
2022
Q1 		$1K Hold
164
– – ﹤0.01% 2154
2021
Q4 		$1K Sell
164
-262
-62% -$1.31K ﹤0.01% 1871
2021
Q3 		$2K Hold
426
– – ﹤0.01% 1491
2021
Q2 		$2K Hold
426
– – ﹤0.01% 1550
2021
Q1 		$3K Hold
426
– – ﹤0.01% 1389
2020
Q4 		$2K Hold
426
– – ﹤0.01% 1420
2020
Q3 		$2K Hold
426
– – ﹤0.01% 1354
2020
Q2 		$2K Hold
426
– – ﹤0.01% 1347
2020
Q1 		$1K Buy
426
+262
+160% +$1.11K ﹤0.01% 1379
2019
Q4 		$1K Buy
+164
New +$570 ﹤0.01% 1353

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lindbrook Capital's AMRX Position: Q1 2025 in Review

Lindbrook Capital held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2025 at 511 shares worth $4.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Lindbrook Capital first reported a position in AMRX in Q4 2019 and has held it in 21 quarters since. 237 funds tracked by Wall St. Rank hold AMRX as of Q1 2025.

  • Lindbrook Capital held 511 shares of Amneal Pharmaceuticals worth $4.28K as of Q1 2025.
  • Lindbrook Capital left its Amneal Pharmaceuticals share count unchanged in Q1 2025.
  • Amneal Pharmaceuticals made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2016 holding.
  • Lindbrook Capital first reported a position in Amneal Pharmaceuticals in Q4 2019 and has held it in 21 quarters since.
  • 237 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.